open access

  • Abstract viewed - 234 times
  • PDF downloaded - 110 times


Purpose: To evaluate clinical outcomes of patients implanted with the Clareon® monofocal intraocular lens (IOL) with AutonoMe™, an automated disposable preloaded delivery device.
Design: Retrospective review.
Methods: One hundred and eight eyes of 88 patients underwent uneventful phacoemulsification cataract surgery and implantation with the Clareon IOL. The primary endpoints were best-corrected distance acuity (BCDA), uncorrected distance acuity (UCDA), and proportion of patients achieving UCDA of logarithm of Minimal Angle of Resolution (logMAR) 0.18 or better at 1 month. Secondary endpoints included refractive stability and predictability, contrast sensitivity as well as wound stretch and surgically induced astigmatism (SIA).
Results: The mean BCDA and UCDA at 1 month were logMAR 0.06 ± 0.08 and 0.18 ± 0.17, respectively. 93.8% of eyes had BCDA of logMAR 0.18 or better, and all eyes had BCDA of logMAR 0.3 or better. 80.9% of eyes had UCDA of 0.18 or better, and 97.8% of eyes had UCDA of 0.3 or better. All eyes were within 0.75 D of refractive target, 90.9% were within 0.5 D, and 68.7% were within 0.25 D. The mean contrast values (logMAR) were 1.73 ± 0.18 at 3 cpd, 1.91 ± 0.24 at 6 cpd, 1.62 ± 0.25 at 12 cpd, and 1.09 ± 0.28 at 18 cpd. Mean wound stretch and centroid SIA for a 2.2 mm incision was 0.04 ± 0.05 mm and 0.10 D, respectively. There was no wound stretch for a 2.4 mm incision and centroid SIA was 0.23 D.
Conclusion: The Clareon IOL provided excellent visual outcomes and good refractive predictability. The AutonoMe delivery system did not cause significant corneal wound stretch or astigmatism.

Most read articles by the same author(s)